2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Carnitine Palmitoyltransferase (CPT)
  5. CPT-2 Isoform

CPT-2

Carnitine Palmitoyltransferase 2; Carnitine-O-Palmitoyltransferase 2; CPT II

 

CPT-2 Related Products (9):

Cat. No. Product Name Effect Purity
  • HY-B1334A
    Perhexiline maleate
    		Inhibitor 99.97%
    Perhexiline maleate is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline maleate induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline maleate can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline maleate can be used in the research of cancers, and cardiovascular disease like angina.
  • HY-113256
    Linoleyl carnitine
    		99.8%
    Linoleyl carnitine is an acylcarnitine and metabolite. Linoleyl carnitine in the liver is negatively correlated with pantothenic acid and citric acid in serum. Linoleyl carnitine accumulates in mitochondrial CPT II deficiency.
  • HY-B1334
    Perhexiline
    		Inhibitor 99.96%
    Perhexiline is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline can be used in the research of cancers, and cardiovascular disease like angina.
  • HY-RS23907
    Cpt2 Rat Pre-designed siRNA Set A
    		Inhibitor
    Cpt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cpt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS03125
    CPT2 Human Pre-designed siRNA Set A
    		Inhibitor

    CPT2 Human Pre-designed siRNA Set A contains three designed siRNAs for CPT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-175673
    LCB-2151
    		Inhibitor
    LCB-2151 (Compound 2), a nucleoside analogue, is an anticancer agent. LCB-2151 disrupts the two primary sources of ATP production (glycolysis and mitochondrial oxidative phosphorylation), reducing the bioenergetic capacity of KRAS-mutated pancreatic cancer cells and inducing ROS formation. LCB-2151 effectively inhibits key enzymes (such as CACT and CPT2) in glycolysis, the TCA cycle and fatty acid β-oxidation. LCB-2151 has significant cytotoxicity and induces cells apoptosis. LCB-2151 can be used for radiation therapy of cancers research.
  • HY-B1334AS
    Perhexiline-d11 maleate
    		Inhibitor
    Perhexiline-d11 (maleate) is the deuterium labeled Perhexiline maleate. Perhexiline maleate is a potent carnitine palmitoyltransferase 1 (CPT 1) inhibitor with IC50s of 77 and 148 μM for rat heart and liver CPT 1, respectively.
  • HY-B1334AR
    Perhexiline maleate (Standard)
    		Inhibitor
    Perhexiline (maleate) (Standard) is the analytical standard of Perhexiline (maleate). This product is intended for research and analytical applications. Perhexiline maleate is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline maleate induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline maleate can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline maleate can be used in the research of cancers, and cardiovascular disease like angina.
  • HY-RS17451
    Cpt2 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Cpt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cpt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.